Prawo i regulacje · 03/05/2007

DEA Places Lisdexamfetamine in Schedule II of Controlled Substances Act

The Drug Enforcement Administration has finalized a rule placing lisdexamfetamine, a stimulant medication, under the same regulatory controls as other Schedule II substances, affecting its manufacture, distribution, and use.